Literature DB >> 20001799

Epigenetics of neurological cancers.

Shaun D Fouse1, Joseph F Costello.   

Abstract

Epigenetic mechanisms involving DNA methylation, histone modifications and noncoding RNAs regulate and maintain gene-expression states. Similar to genetic mutations, alterations in epigenetic regulation can lead to uncontrolled cell division, tumor initiation and growth, invasiveness and metastasis. Research in brain cancer, particularly gliomas, has uncovered global and gene-specific DNA hypomethylation, local DNA hypermethylation of gene promoters and the de-regulation of microRNA expression. Understanding epigenetic dysregulation in brain cancers has provided new tools for prognostication, as well as suggesting new approaches to therapy. There is significant interest in new sequencing-based technologies that map genetic and epigenetic alterations comprehensively and at high resolution. These methods are being applied to brain tumors, and will better define the contribution of epigenetic defects to tumorigenesis.

Entities:  

Mesh:

Year:  2009        PMID: 20001799      PMCID: PMC4018230          DOI: 10.2217/fon.09.132

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  161 in total

1.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.

Authors:  X Nan; H H Ng; C A Johnson; C D Laherty; B M Turner; R N Eisenman; A Bird
Journal:  Nature       Date:  1998-05-28       Impact factor: 49.962

2.  Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases.

Authors:  M Okano; S Xie; E Li
Journal:  Nat Genet       Date:  1998-07       Impact factor: 38.330

3.  O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy.

Authors:  J R Silber; A Blank; M S Bobola; S Ghatan; D D Kolstoe; M S Berger
Journal:  Clin Cancer Res       Date:  1999-04       Impact factor: 12.531

4.  Genomic alterations of human gliomas detected by restriction landmark genomic scanning.

Authors:  M Nakamura; N Konishi; S Tsunoda; Y Hiasa; K Takemura; T Tsuzuki; K Kobitsu; T Sakaki
Journal:  Brain Tumor Pathol       Date:  1997       Impact factor: 3.298

5.  MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex.

Authors:  H H Ng; Y Zhang; B Hendrich; C A Johnson; B M Turner; H Erdjument-Bromage; P Tempst; D Reinberg; A Bird
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

6.  Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.

Authors:  M Esteller; S R Hamilton; P C Burger; S B Baylin; J G Herman
Journal:  Cancer Res       Date:  1999-02-15       Impact factor: 12.701

7.  Genetic variations in recurrent astrocytic tumors detected by restriction landmark genomic scanning.

Authors:  M Nakamura; N Konishi; T Inui; Y Hiasa; H Nagai; S Tsunoda; H Nakase; T Tsuzuki; H Aoki; H Sakitani; N Aoyama; T Sakaki
Journal:  Brain Tumor Pathol       Date:  1998       Impact factor: 3.298

8.  DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.

Authors:  H S Friedman; R E McLendon; T Kerby; M Dugan; S H Bigner; A J Henry; D M Ashley; J Krischer; S Lovell; K Rasheed; F Marchev; A J Seman; I Cokgor; J Rich; E Stewart; O M Colvin; J M Provenzale; D D Bigner; M M Haglund; A H Friedman; P L Modrich
Journal:  J Clin Oncol       Date:  1998-12       Impact factor: 44.544

9.  Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study.

Authors:  K A Jaeckle; H J Eyre; J J Townsend; S Schulman; H M Knudson; M Belanich; D B Yarosh; S I Bearman; D J Giroux; S C Schold
Journal:  J Clin Oncol       Date:  1998-10       Impact factor: 44.544

10.  Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.

Authors:  E E Cameron; K E Bachman; S Myöhänen; J G Herman; S B Baylin
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

View more
  10 in total

Review 1.  MGMT promoter methylation in malignant gliomas.

Authors:  Markus J Riemenschneider; Monika E Hegi; Guido Reifenberger
Journal:  Target Oncol       Date:  2010-08-20       Impact factor: 4.493

2.  DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors.

Authors:  Tali Mazor; Aleksandr Pankov; Brett E Johnson; Chibo Hong; Emily G Hamilton; Robert J A Bell; Ivan V Smirnov; Gerald F Reis; Joanna J Phillips; Michael J Barnes; Ahmed Idbaih; Agusti Alentorn; Jenneke J Kloezeman; Martine L M Lamfers; Andrew W Bollen; Barry S Taylor; Annette M Molinaro; Adam B Olshen; Susan M Chang; Jun S Song; Joseph F Costello
Journal:  Cancer Cell       Date:  2015-09-14       Impact factor: 31.743

3.  Differentially expressed genes in giant cell tumor of bone.

Authors:  Erica Babeto; André Luis Giacometti Conceição; Marina Curado Valsechi; Paulo Peitl Junior; Débora Aparecida Pires de Campos Zuccari; Luiz Guilherme Cernaglia Aureliano de Lima; Jane Lopes Bonilha; Marília de Freitas Calmon; José Antônio Cordeiro; Paula Rahal
Journal:  Virchows Arch       Date:  2011-02-09       Impact factor: 4.064

Review 4.  Epigenetic modifications as therapeutic targets.

Authors:  Theresa K Kelly; Daniel D De Carvalho; Peter A Jones
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

5.  Identifying Novel Glioma-Associated Noncoding RNAs by Their Expression Profiles.

Authors:  Alenka Matjašič; Mojca Tajnik; Emanuela Boštjančič; Mara Popović; Boštjan Matos; Damjan Glavač
Journal:  Int J Genomics       Date:  2017-09-12       Impact factor: 2.326

Review 6.  Pioneer Role of Extracellular Vesicles as Modulators of Cancer Initiation in Progression, Drug Therapy, and Vaccine Prospects.

Authors:  Sadaf Jahan; Shouvik Mukherjee; Shaheen Ali; Urvashi Bhardwaj; Ranjay Kumar Choudhary; Santhanaraj Balakrishnan; Asma Naseem; Shabir Ahmad Mir; Saeed Banawas; Mohammed Alaidarous; Hadeel Alyenbaawi; Danish Iqbal; Arif Jamal Siddiqui
Journal:  Cells       Date:  2022-01-31       Impact factor: 6.600

7.  Epigenetic Methylation of Parathyroid CaR and VDR Promoters in Experimental Secondary Hyperparathyroidism.

Authors:  Jacob Hofman-Bang; Eva Gravesen; Klaus Olgaard; Ewa Lewin
Journal:  Int J Nephrol       Date:  2012-10-10

8.  A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency.

Authors:  Yu Liang; Debra Quenelle; Jodi L Vogel; Cristina Mascaro; Alberto Ortega; Thomas M Kristie
Journal:  mBio       Date:  2013-02-05       Impact factor: 7.867

Review 9.  The Role of Extracellular Vesicles: An Epigenetic View of the Cancer Microenvironment.

Authors:  Zhongrun Qian; Qi Shen; Xi Yang; Yongming Qiu; Wenbin Zhang
Journal:  Biomed Res Int       Date:  2015-10-25       Impact factor: 3.411

10.  Epigenetic Modification and Differentiation Induction of Malignant Glioma Cells by Oligo-Fucoidan.

Authors:  Chien-Huang Liao; I-Chun Lai; Hui-Ching Kuo; Shuang-En Chuang; Hsin-Lun Lee; Jacqueline Whang-Peng; Chih-Jung Yao; Gi-Ming Lai
Journal:  Mar Drugs       Date:  2019-09-08       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.